Broadwood Partners, L.P. and its affiliates, holders of approximately 27.5% of the outstanding common stock of Staar Surgical Company (STAA), announced that it has published a presentation outlining why stockholders should vote on Broadwood’s GREEN Proxy Card “AGAINST” the proposed acquisition of the company by an affiliate of Alcon (ALC) on the terms announced on August 5, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Alcon, Staar Surgical announce expiration of HSR waiting period
- Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
- Staar Surgical sees FY26 revenue $340M, consensus $319.33M
- Staar Surgical Announces Proposed Merger with Alcon
- Staar Surgical reports expiration of window shop period under Alcon merger pact